Introducing IGIS, a versatile, scalable platorm to investigate synthetic lethal relationships between cancer therapeutic targets. Haracska et al. describe the platform and validate it by investigation of BRCA1–RAD18 interplay. New in NAR Cancer. academic.oup.com/narcancer/ar...
Abstract. Synthetic lethality offers opportunities to identify therapeutic targets for cancer research, facilitating the development of targeted tumour the
